Receptor, Cannabinoid, CB1, antagonists & inhibitors
DBCAT001661Pharmacologic class
A DrugBank category of 6 drugs. 1 of them is approved.
What you can answer from here — as of June 29, 2018
Which targets do Receptor, Cannabinoid, CB1, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account